Genetic Predisposition to Cancer, An Issue of Hematology/Oncology Clinics of North America, 1st Edition
Author :
By Ken Offit, MD, MPH and Mark Robson, MD
This issue serves as a timely review of both the genetic and genomic factors resulting in a predisposition to human cancer. There is now strong evidence to support the use of genetic testing for cancer predisposition in the practice of preventive me
...view more
This issue serves as a timely review of both the genetic and genomic factors resulting in a predisposition to human cancer. There is now strong evidence to support the use of genetic testing for cancer predisposition in the practice of preventive medicine, and at the same time, there is emerging new literature defining the role of genomic approaches to assessment of cancer predisposition. Articles address predisposition syndromes in the areas of breast cancer, lower GI cancer, genitourinary cancer, pediatric cancer, endocrine cancer, and hematologic malignancy.
This issue serves as a timely review of both the genetic and genomic factors resulting in a predisposition to human cancer. There is now strong evidence to support the use of genetic testing for cancer predisposition in the practice of preventive medicine, and at the same time, there is emerging new literature defining the role of genomic approaches to assessment of cancer predisposition. Articles address predisposition syndromes in the areas of breast cancer, lower GI cancer, genitourinary cancer, pediatric cancer, endocrine cancer, and hematologic malignancy.
https://www.asia.elsevierhealth.com/genetic-predisposition-to-cancer-an-issue-of-hematologyoncology-clinics-of-north-america-9781437722048.html299692Genetic Predisposition to Cancer, An Issue of Hematology/Oncology Clinics of North Americahttps://www.asia.elsevierhealth.com/media/catalog/product/9/7/9781437722048_8.jpg74.2498.99USDInStock/Clinics/Medicine & Surgery/Oncology/Medicine/Oncology/Clinics/Clinics/Medicine/Oncology/Japan Titles43887254335180505458550546665255041525986752631601418269243350884886536505455351451205259833This issue serves as a timely review of both the genetic and genomic factors resulting in a predisposition to human cancer. There is now strong evidence to support the use of genetic testing for cancer predisposition in the practice of preventive medicine, and at the same time, there is emerging new literature defining the role of genomic approaches to assessment of cancer predisposition. Articles address predisposition syndromes in the areas of breast cancer, lower GI cancer, genitourinary cancer, pediatric cancer, endocrine cancer, and hematologic malignancy. This issue serves as a timely review of both the genetic and genomic factors resulting in a predisposition to human cancer. There is now strong evidence to support the use of genetic testing for cancer predisposition in the practice of preventive medicine, and at the same time, there is emerging new literature defining the role of genomic approaches to assessment of cancer predisposition. Articles address predisposition syndromes in the areas of breast cancer, lower GI cancer, genitourinary cancer, pediatric cancer, endocrine cancer, and hematologic malignancy.00add-to-cart97814377220482011 and earlierProfessionalBy Ken Offit, MD, MPH and Mark Robson, MD20101Book152w x 229h (6.00" x 9.00")Saunders0Sep 28, 2010IN STOCKBy <STRONG>Ken Offit</STRONG>, MD, MPH and <STRONG>Mark Robson</STRONG>, MDClinicsClinicsThe Clinics: Internal MedicineUnited StatesNoNoNoNoPlease SelectPlease SelectPlease Select